Panel Discussion: Injectable therapies 2.0: Driving patient-friendly parenteral drug delivery

Panellists in this video:
+ Dr Rakesh Bhasin, Head – Generic Formulation R&D, Biocon (MODERATOR)
+ Mr Makarand Avachat, EVP, Lupin
+ Dr Ravikumar N, EVP, MSN Laboratories
+ Dr Sukhjeet Singh, Chief Scientific Officer, Acme Formulation
+ Dr Mallinath S Harwalkar, VP – R&D, Hetero
+ Dr Amarender Reddy Donthidi, VP & Head – R&D Injectables and Ophthalmics, Amneal Pharmaceuticals
+ Dr Krishna Bhavanasi, VP- F&D, Torrent Pharmaceuticals

Key Highlights:
[1] Innovations like depot injections are enabling long-acting formulations and improving patient adherance through weekly or monthly dosing

[2] Smart injectables and wearable injectors are making home administration easier and safer

[3] Growth in complex injectable biologics is driving the need for novel delivery systems

[4] Industry is exploring painless injections as part of improving patient experience. Efforts include using bigger needles or higher volume to reduce pain during administration.

[5] There’s a growing interest in reusable injection devices, including reusable pens.

[6] Innovation is limited—current developments mostly involve reworking existing needle technologies rather than introducing new solutions.

[7] We need to create and incentivise an ecosystem that encourages more innovation.